Glycogen synthase kinase 3β in Toll-like receptor signaling

키워드

참고문헌 (50)

1. Medzhitov R, "Innate immunity:the virtues of a nonclonal system of recognition", Cell, 91, pp.295~298 (1997)
2. Akira S, "Toll-like receptor signalling", Nat Rev Immunol, 4, pp.499~511 (2004)
3. Akira S, "Pathogen recognition and innate immunity", Cell, 124, pp.783~801 (2006)
4. Kawai T, "The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors", Nat Immunol, 11, pp.373~384 (2010)
5. Kawagoe T, "Sequential control of Toll-like receptor-dependent responses by IRAK1 and IRAK2", Nat Immunol, 9, pp.684~691 (2008)
6. Bhoj VG, "Ubiquitylation in innate and adaptive immunity", Nature, 458, pp.430~437 (2009)
7. Oganesyan G, "Critical role of TRAF3 in the Toll-like receptor-dependent and-independent antiviral response", Nature, 439, pp.208~211 (2006)
8. Meylan E, "RIP1 is an essential mediator of Toll-like receptor 3-induced NFkappa B activation", Nat Immunol, 5, pp.503~507 (2004)
9. Embi N, "Glycogen synthase kinase-3 from rabbit skeletal muscle. Separation from cyclic-AMP-dependent protein kinase and phosphorylase kinase", Eur J Biochem, 107, pp.519~527 (1980)
10. Woodgett JR, "Molecular cloning and expression of glycogen synthase kinase-3", factor A, 1990, pp.9, 2431~2438
11. Force T, "Unique and overlapping functions of GSK-3 isoforms in cell differentiation and proliferation and cardiovascular development", J Biol Chem, 284, pp.9643~9647 (2009)
12. Doble BW, "GSK-3 : tricks of the trade for a multi-tasking kinase", J Cell Sci, 116, pp.1175~1186 (2003)
13. Jope RS, "The glamour and gloom of glycogen synthase kinase-3", Trends Biochem Sci, 29, pp.95~102 (2004)
14. Rayasam GV, "Glycogen synthase kinase 3: more than a namesake", Br J Pharmacol, 156, pp.885~898 (2009)
15. Cross DA, "Insulin activates protein kinase B, inhibits glycogen synthase kinase-3 and activates glycogen synthase by rapamycininsensitive pathways in skeletal muscle and adipose tissue", FEBS Lett, 406, pp.211~215 (1997)
16. Bax B, "The structure of phosphorylated GSK-3beta complexed with a peptide, FRATtide, that inhibits beta-catenin phosphorylation", Structure, 9, pp.1143~1152 (2001)
17. Beurel E, "Innate and adaptive immune responses regulated by glycogen synthase kinase-3(GSK3)", Trends Immunol, 31, pp.24~31 (2010)
18. Wang H, "Glycogen synthase kinase 3: a point of convergence for the host inflammatory response", Cytokine, 53, pp.130~140 (2011)
19. Wang H, "GSK3β and the control of infectious bacterial diseases", Trends Microbiol, 22, pp.208~217 (2014)
20. Ko R, "Glycogen synthase kinase 3β ubiquitination by TRAF6 regulates TLR3-mediated pro-inflammatory cytokine production", Nat Commun, 6, pp.6765~ (2015)
21. Medzhitov R, "A human homologue of the Drosophila Toll protein signals activation of adaptive immunity", Nature, 388, pp.394~397 (1997)
22. Poltorak A, "Defective LPS signaling in C3H", HeJ and C57BL, Science, pp.1998, 282[DOI]
23. Arbibe L, "Toll-like receptor 2-mediated NF-kappa B activation requires a Rac1-dependent pathway", Nat Immunol, 1, pp.533~540 (2000)
24. Guha M, "The phosphatidylinositol 3-kinase-Akt pathway limits lipopolysaccharide activation of signaling pathways and expression of inflammatory mediators in human monocytic cells", J Biol Chem, 277, pp.32124~32132 (2002)
25. Martin M, "Toll-like receptor-mediated cytokine production is differentially regulated by glycogen synthase kinase 3", Nat Immunol, 6, pp.777~784 (2005)
26. Wang H, "Convergence of the mammalian target of rapamycin complex 1-and glycogen synthase kinase 3-β-signaling pathways regulates the innate inflammatory response", J Immunol, 186, pp.5217~5226 (2011)
27. Nandan D, "Myeloid cell IL-10 production in response to leishmania involves inactivation of glycogen synthase kinase-3β downstream of phosphatidylinositol-3kinase", J Immunol, 188, pp.367~378 (2012)
28. Paul J, "TLR mediated GSK3β activation suppresses CREB mediated IL-10 production to induce a protective immune response against murine visceral leishmaniasis", Biochimie, 107, pp.235~246 (2014)
29. Rehani K, "Toll-like receptor-mediated production of IL-1Ra is negatively regulated by GSK3 via the MAPK ERK1", 2, 2009, pp.182, 547~553
30. Beurel E, "GSK3 promotes the synergistic action of interferon-gamma on lipopolysaccharide-induced IL-6 production in RAW264. 7 cells", Cell Signal, 21, pp.978~985 (2009)
31. Noh KT, "GSK-3β-induced ASK1 stabilization is crucial in LPSinduced endotoxin shock", Exp Cell Res, 317, pp.1663~1668 (2011)
32. Wang H, "IFN-beta production by TLR4-stimulated innate immune cells is negatively regulated by GSK3-beta", J Immunol, 181, pp.6797~6802 (2008)
33. Ozinsky A, "The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between Toll-like receptors", Proc Natl Acad Sci U S A, 97, pp.13766~13771 (2000)
34. Farhat K, "Heterodimerization of TLR2 with TLR1 or TLR6 expands the ligand spectrum but does not lead to differential signaling", J Leukoc Biol, 83, pp.692~701 (2008)
35. Borrello S, "TLR2: a crossroads between infections and autoimmunity?", Int J Immunopathol Pharmacol, 24, pp.549~556 (2011)
36. Hu X, "IFN-gamma suppresses IL-10 production and synergizes with TLR2 by regulating GSK3 and CREB", AP-1 proteins, 2006, pp.24, 563~574
37. Zhang P, "Glycogen synthase kinase-3beta(GSK3beta)inhibition suppresses the inflammatory response to Francisella infection and protects against tularemia in mice", Mol Immunol, 46, pp.677~687 (2009)
38. Cheng YL, "Staphylococcus aureus induces microglial inflammation via a glycogen synthase kinase 3beta-regulated pathway", Infect Immun, 77, pp.4002~4008 (2009)
39. Cortés-Vieyra R, "The Glycogen Synthase Kinase 3α and β Isoforms Differentially Regulates Interleukin-12p40 Expression in Endothelial Cells Stimulated with Peptidoglycan from Staphylococcus aureus", PLoS One, 10, pp.e0132867~ (2015)
40. Alexopoulou L, "Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3", Nature, 413, pp.732~738 (2001)
41. Matsumoto M, "TLR3: interferon induction by double-stranded RNA including poly(I:C)", Adv Drug Deliv Rev, 60, pp.805~812 (2008)
42. Perales-Linares R, "Toll-like receptor 3 in viral pathogenesis: friend or foe?", Immunology, 140, pp.153~167 (2013)
43. Yamamoto M, "Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway", Science, 301, pp.640~643 (2003)
44. Fitzgerald KA, "IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway", Nat Immunol, 4, pp.491~496 (2003)
45. Hiscott J, "Triggering the innate antiviral response through IRF-3 activation", J Biol Chem, 282, pp.15325~15329 (2007)
46. Sato S, "Toll", IL-1 receptor domain-containing adaptor inducing IFN-beta(TRIF)associates with TNF receptor-associated factor 6 and TANK-binding kinase 1, and activates two distinct transcription factors, NF-kappa B and IFNregulatory factor-3, in the Toll-like receptor signaling, 2003, pp.171, 4304~4310
47. Meylan E, "RIP1 is an essential mediator of Toll-like receptor 3-induced NF-kappa B activation", Nat Immunol, 5, pp.503~507 (2004)
48. Kawai T, "The roles of TLRs, RLRs and NLRs in pathogen recognition", Int Immunol, 21, pp.317~337 (2009)
49. Chattopadhyay S, "dsRNA-activation of TLR3 and RLR signaling: gene induction-dependent and independent effects", J Interferon Cytokine Res, 34, pp.427~436 (2014)
50. Lei CQ, "Glycogen synthase kinase 3β regulates IRF3 transcription factormediated antiviral response via activation of the kinase TBK1", Immunity, 33, pp.878~889 (2010)